Last edition
News about "bronchospasm"
Strides Gets FDA Approval for Theophylline Extended-Release Tablets
Theophylline Extended-Release Tablets, 300 mg and 450 mg have a combined market size of ~USD 11.5 million, with the 300 mg dosage contributing ~USD 10.8 million.
Bronchospasm | 06/09/2024 | By Aishwarya | 113
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members